Caprock Group, Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Caprock Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$83.14 - $145.99 $294,814 - $517,680	-3,546 Closed	0 $0
Q1 2022 Apr 12, 2022	BUY	$110.08 - $142.92 $117,345 - $152,352	1,066 Added 42.98%	3,546 $420,000
Q4 2021 Jan 18, 2022	BUY	$99.73 - $148.48 $29,819 - $44,395	299 Added 13.71%	2,480 $342,000
Q3 2021 Oct 07, 2021	BUY	$98.85 - $138.91 $215,591 - $302,962	2,181 New	2,181 $303,000

565K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.49B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.